Medtronic reports 6 percent rise in quarterly revenue Medical Dialogues Bureau22 Nov 2018 9:32 AM ISTNew Delhi: Medical device maker Medtronic plc reported a 6 per cent rise in quarterly revenue on Tuesday, helped by higher sales in its cardiac and...
Dr. Reddy's shares spike after favourable generic drug ruling Medical Dialogues Bureau22 Nov 2018 9:21 AM ISTNew Delhi: Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 per cent on Wednesday, their sharpest intraday gain in a year after...
Roche-AbbVie cancer drug, Venclexta gets accelerated FDA approval Medical Dialogues Bureau22 Nov 2018 9:15 AM ISTNew Delhi: Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as...
FDA approves new blood cancer treatment from Pfizer Medical Dialogues Bureau22 Nov 2018 9:15 AM ISTThe U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
Mylan recalls batches of Valsartan in US. Medical Dialogues Bureau21 Nov 2018 11:05 AM ISTMylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a...
MTaI demands upto 18 percent price hike of medical devices Medical Dialogues Bureau21 Nov 2018 10:54 AM ISTHike required to neutralize the impact of rupee depreciation & inflationNew Delhi: Medical Technology Association of India (MTaI), which...
Zydus Cadila gets USFDA nod to market generic Deferasirox tablets Medical Dialogues Bureau21 Nov 2018 10:44 AM ISTNew Delhi: Drug firm Zydus Cadiz Tuesday said it has received the tentative nod from the US health regulator to market generic Deferasirox tablets...
Glenmark gets USFDA nod for generic acne treatment gel Medical Dialogues Bureau21 Nov 2018 9:00 AM ISTNew Delhi: Glenmark Pharmaceuticals Tuesday said it has received approval from the US health regulator for Azelaic Acid gel used in the treatment of...
EU cracks down on Valsartan- blood pressure medicine made by Mylan Medical Dialogues Bureau20 Nov 2018 12:05 PM ISTThe batches of Valsartan were found to contain N-nitrosodiethylamine (NDEA), a probable carcinogen, and were made in Mylan's Hyderabad facility in...
Greece eyes pot of gold as medicinal cannabis licensed Medical Dialogues Bureau20 Nov 2018 9:00 AM ISTATHENS - Greece on Monday issued the first licences to private companies for growing medicinal cannabis in the country, part of an attempt to tap a...
GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA Medical Dialogues Bureau19 Nov 2018 1:47 PM ISTNew Delhi: General Electric Co has recently announced its lending arm has sold a $1.5 billion healthcare equipment finance portfolio to U.S. lender...
Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 1:14 PM ISTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
